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SUMMARY 
As a partner in the STEP UP research 
programme consortium, Marie Stopes 
International has conducted high-quality 
research and enabled significant impact on 
health policies and programming. STEP UP 
research on quality of care for medical abortion 
(MA) has provided the evidence base for 
strengthening of MSI’s provision of safe 
abortion, specifically MA, across the globe, 
enabling such impact as:  
 
 Development of MSI’s safe abortion and 
post-abortion care strategy and best 
practice guidance for implementation 
 
 Development and implementation of 
mechanisms to ensure women obtaining 
MA from pharmacies have access to 
information (including telephone advice line 
services and improved product packaging 
information)  
  
STEP UP generates 
policy-relevant research 
to promote an evidence-
based approach for 
improving access to  
family planning and  
safe abortion.  
 
We work in Bangladesh, 
northern India, Ghana, 
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 Implementation of ongoing 
pharmacy education and provision 
of informational materials to 
expand awareness of MA  
AUGUST 2018 
FROM EVIDENCE TO IMPACT: A look at how STEP UP 
research was used to impact policies and programmes 
The goal of family planning and reproductive health operations research is to generate 
evidence that helps policies and programmes maximize access to and quality of services 
for women and their families. Yet the crucial step of ensuring the utilization of that 
evidence often receives inconsistent or inadequate attention. There is relatively little 
monitoring and reporting on whether and to what effect research findings are utilized, or 
on the nature, process, and efficacy of the strategies employed to achieve this.  
The goal of this case study is to document an activity of the STEP UP research 
programme consortium which resulted in successful evidence utilization. This is to both 
demonstrate the positive impact STEP UP is having on family planning and reproductive 
health policies, as well as to document the process by which this was achieved so as to 





The availability of misoprostol and mifepristone in 
pharmacies and drug shops has increased women’s 
access to safe, non-surgical methods of abortion in many 
countries, resulting in declines in mortality and morbidity 
from unsafe abortion.1 Yet women’s access to accurate 
information about these medications remains limited, 
especially when the drug sellers themselves lack 
adequate information and training. Without access to 
accurate information as well as high quality products, 
incorrect use of medical abortion drugs may limit their 
effectiveness.  
 
Marie Stopes International (MSI), a research partner in 
STEP UP, has been uniquely positioned to produce, 
implement and scale up STEP UP evidence, resulting in 
research uptake at both a regional and global level by 




Two primary STEP UP activities informed MSI’s safe 
abortion and post-abortion care strategy and ongoing 
programme improvements:  
 A systematic review examining published studies 
assessing the level and quality of pharmacy and drug 
shop provision of medical abortion in low- and middle-
income countries, as well as interventions to improve 
quality of provision.2 
 A study assessing the availability, use, and quality of 
care for MA provision in private pharmacies in  
Kenya. 3 
Without access to accurate 
information as well as high quality 
products, incorrect use of medical 
abortion drugs may limit their 
effectiveness. 
KEY STUDY RESULTS 
In Kenya,  
 Pharmacy workers are providing women with MA 
drugs and information: 62% of pharmacy workers 
provided information on abortion methods to mystery 
shoppers, and 28% offered MA drugs.  
 Demand for abortion services is high: pharmacies that 
provide MA information and drugs reported an 
average of 12 women seeking abortion services per 
month. Among pharmacies that do not provide MA 
information and drugs, most (74%) said that their 
clients ask for these services. 
 However, pharmacy workers do not know correct MA 
regimens, side effects, or the legal status of MA. Only 
9% of pharmacy workers could state the correct WHO 
approved mifepristone-misoprostol MA regimen. 
Knowledge of the misoprostol-only regimen was 
higher (19%).  
 Among those who did know the correct regimen, 
many were unable to name side effects or potential 
complications.  
 Pharmacy workers need and want more training on 
MA methods, recognition and management of 
complications, referrals, and abortion law. 
 
Globally: 
 Despite widespread awareness and provision of MA 
drugs, most studies found that pharmacy workers and 
drug sellers had poor knowledge of effective regimens 
 Evidence on interventions to improve pharmacy 
provision of MA indicated that training, call centre 
support, and medical detailing could be effective in 
improving drug seller knowledge, but evidence was 
limited and generally of poor quality.  
 Programmatic attention should focus on the 
development and rigorous evaluation of innovative 
interventions to improve women’s access to 




MAKING AN IMPACT 
Marie Stopes International has over 600 fixed clinics, 3,600 
social franchises, 520 outreach teams, and 550 community 
midwives in 37 countries. To inform MSI clinical guidelines 
and practices is to contribute to improving the care of 
millions of women. STEP UP evidence on pharmacy 
provision of MA has been utilized by MSI in several ways: 
 
Supporting high quality MA information provision by 
pharmacy workers in Kenya 
Training sessions on MA were conducted with pharmacy 
staff, doctors, nurses and clinical officers by Marie Stopes 
Kenya (MSK), including MSK staff and non-MSK staff. 
STEP UP research data informed the training content and 
improved educational materials, as the research had 
identified the greatest knowledge gaps for these providers. 
To improve access to information for MA users, MSK also 
actively promoted their call centre phone number to 
pharmacies and their clients by printing the call centre 
phone number on promotional materials and packaging. 
The survey had shown that many pharmacists provided 
MA drugs without any packaging, information, or support, 
so this intervention aimed to ensure that women would 
have access to the required information and support after 
leaving the pharmacy. 
 
Building a global strategy for safe abortion and post-
abortion care 
The research has also influenced MSI’s global safe 
abortion and post-abortion care strategy, which was 
developed in 2016-17. As a result of this evidence on 
pharmacy provision of MA, the strategy highlights the 
importance of improving access to information about MA 
for women who may be using these products (within the 
local legal framework), as well as improving access to 
information among health professionals such as 
pharmacists. The strategy offers programmes guidance 
and advice on how to achieve this through evidence-based 
case studies, such as that of Marie Stopes Kenya.  
 
Strengthening MSI call centres as key drivers for 
improving sexual and reproductive health awareness  
The STEP UP systematic review revealed the need for 
improved knowledge and awareness of MA, and the 
important role that hotlines and call centres can play in 
ensuring women have access to information. MSI’s safe 
abortion and post-abortion care strategy recognises the 
key role of the call centre for providing information and 
referrals.  
 
A call centre toolkit for MSI programmes has been 
developed, and programmes are supported to 
strengthen their call centres through continuing 
investment in technical expertise and resources. The 
impact of call centres on women’s access to accurate 
information about MA is now being evaluated in 
Zambia.  
 
KEY LESSONS LEARNED 
The vertically integrated structure of MSI allowed for 
efficient and widespread uptake of STEP UP evidence. 
Research is able to inform not only operations 
(enhancing service delivery) but also strategy 
development (ensuring relevance, innovation, and 
sustained benefits of services to communities). 
 
A feedback system of operations 
research and operational guidance   
Several aspects of MSI internal structure enabled 
successful research uptake of STEP UP evidence.  
Informing best practice  
MSI uses ‘Success Models’ to capture all best practice 
guidance for operations, including evidenced examples 
of how guidance has been successfully implemented in 
particular country programmes. The ‘Success Models’ 
are documents which identify key rules or 
recommendations for successful implementation of 
each of MSI’s service delivery channels (fixed clinics, 
mobile outreach teams, social franchise, community 
midwives, public sector support), and for specific 
technical areas such as safe abortion and post-
abortion care, and reaching adolescents.  
Each rule or recommendation includes guidance on its 
rationale, how to implement, and evidenced examples 
of where it has been successfully implemented. 
Through this continuing feedback loop, new evidence 
informs best practice guidance and programmatic 
decision-making.   
Investing in evidence  
The feedback loop of ‘Success Models’ also helps to 
identify where more evidence is needed in order to 
improve operations, expand access, or strengthen 
quality. For example, if there is a lack of evidence for a 
specific intervention, or it is unclear how to address an 
operational challenge, this will be prioritised as an area 
where more research is needed.  
 
Investment in evidence at MSI is based on twelve 
strategic research priorities4 that were defined in 2016 
during a cross-MSI research scoping and prioritisation 
effort. Alongside the Success Models, the MSI research 
strategy aligns the organisation in terms of priorities for 
investment in evidence generation. To ensure 
sustainable impact, to the maximum extent possible, 
strategic and operational research questions are 
answered using routine data as MSI has a wide range 
of high quality data sources such as its electronic 
health information system.  
Communicating results  
To ensure maximum use of new evidence, research is 
integrated into Success Model guidance, and it is 
widely disseminated through global and country 
leadership. This ensures that there is shared 
understanding across the organisation of “what works”. 
Evidence is shared through targeted evidence briefs, 
with clear implications for operations highlighted, and 
wherever possible, wider bodies of evidence are 
collated to show research findings in context.  
 
CONCLUSION  
Pharmacy workers are key in expanding access to safe 
methods of abortion worldwide and reducing harm from 
unsafe abortion. Pharmacy staff require improved 
support to ensure women receive accurate information, 
and mechanisms are needed to expand women’s direct 
access to information about medical abortion. To this 
end, STEP UP research on pharmacy provision of MA 
has been successfully utilized at wide scale throughout 
the MSI network. The embedded partnership of 
research activities and service delivery was the crucial 





Suggested citation:  
Katy Footman, Nancy Termini LaChance. 2018. “Using 
evidence to improve quality of pharmacy-delivered 
medical abortion,” STEP UP Case Study, August 2018. 





© 2018 MARIE STOPES INTERNATIONAL. 
WORKS CITED 
1. Hyman, A., K. Blanchard, F. Coeytaux, D. 
Grossman, and A. Teixeira. 2013. “Misoprostol in 
women’s hands: A harm reduction strategy for 
unsafe abortion” Contraception 87(2): 128–130 
2. Footman, K; Keenan, K; Reiss, K; Reichwein, B; 
Biswas, P; Church, K (2017) ‘A Systematic Review 
of Medical Abortion Provision by Pharmacies and 
Drug Sellers in Low-and Middle-Income Countries’ 
Studies in Family Planning 
3. Reiss, K., K. Footman, V. Akora, W. Liambila, and 
T. D. Ngo. 2016. “Pharmacy workers’ knowledge 
and provision of medication for termination of 
pregnancy in Kenya,” Journal of Family Planning 
and Reproductive Health Care 
4. Marie Stopes International. “Insight to Action: 
MSI’s Research, Monitoring and Evaluation 
Strategy to support Scaling up Excellence 2016-
2020” London: Marie Stopes International.  
 
 
 
